|
ADGC African American Summary Statistics- Reitz et al. (2013) |
|
|
|
|
ADGC case-control summary statistics on 7050 samples not included in the IGAP-2013 discovery stage- Hu et al. (2019) |
|
|
|
|
A novel age-informed approach for genetic association analysis in Alzheimer’s disease summary statistics - Guen et al. 2021 |
|
|
|
|
ADSP Discovery Case/Control Association Results |
|
|
|
|
Progressive Supranuclear Palsy (PSP) Summary Statistics – Farrell et al., 2024 (via DSS) |
|
|
|
|
Novel risk loci and pathways associated with Alzheimer disease in African Americans: A GWAS and meta-analysis summary statistics- Kunkle et al. (2020) |
|
|
|
|
Multi-Ethnic Exome Array Study of AD, FTD, and PSP |
|
|
|
|
Genetic analyses of patients with CTE |
|
|
|
|
CLU, A potential endophenotype for AD: Summary Statistics- Deming et al. (2016) |
|
|
|
|
Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders (via DSS) |
|
|
|
|
ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) |
|
|
|
|
IGAP Summary Statistics, ADGC subset- Lambert et al. (2013) |
|
|
|
|
Genetic variants and functional pathways associated with resilience to Alzheimer’s disease (via DSS) |
|
|
|
|
GWAS Summary Statistics of informed conditioning analysis in African Americans- Mez et al. (2017) |
|
|
|
|
Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease (via DSS) |
|
|
|
|
Laser Capture and RNA sequencing of Microglia in human brain - Mastroeni et al.(2017) |
|
|
|
|
Alzheimer’s disease single-neuron whole-genome sequencing - Miller 2022 (via DSS) |
|
|
|
|
Identifying Rare Variants That Increase Risk For Alzheimer's Disease |
|
|
124675 |
|
Profiling microglia expression profiles in AD using single-nuclei RNA-seq (via DSS) |
|
|
|
|
GWAS of CLU, A potential endophenotype for Alzheimer's disease |
|
|
6015512 |
